De Novo device
Sonablate 450
Sonacare Medical, LLC · High Intensity Ultrasound System For Prostate Tissue Ablation (PLP, Class II) · First FDA decision Oct 9, 2015, newest Oct 9, 2015Prostate cancer
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
2
Naming "Sonablate 450"
MAUDE reports
0
Brand "Sonablate 450", since 2015
PubMed studies
0
Mentioning "Sonablate 450"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sonablate 450
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Sonablate 450New device typeDe Novo
DEN150011 · Decided Oct 9, 2015 · 200 days after receipt
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cryosurgery Ablation for Prostate CancerNational analysisReview closedCAG-00031NUpdated Sep 14, 2026
- Laser Ablation of the ProstateLocal determinationIn effectL34090CGS Administrators, LLCUpdated Mar 25, 2026
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38705Noridian Healthcare Solutions, LLCUpdated Feb 23, 2026
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38549Palmetto GBAUpdated Oct 24, 2025
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38682WPS Insurance CorporationUpdated Oct 21, 2025
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38726First Coast Service Options, Inc.Updated Mar 14, 2025
- Transurethral Waterjet Ablation of the ProstateLocal determinationIn effectL38712Novitas Solutions, Inc.Updated Mar 14, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Sonablate 450", any status and sponsor, newest update first.
University of California, Los AngelesAcademic, hospital or other
NCT03620786 · 100 participants (planned) · Start Sep 26, 2018 · Primary completion Jan 31, 2027
Device: Sonablate HIFU device · For: Prostate Cancer
Sites: Los Angeles, California
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sonablate 450", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PLP
33 reports: 1 malfunction, 31 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sonablate 450"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PLP.
- TULSA-PRO SystemProfound Medical, Inc. · 510(k) 2023
- Focal One®Edap Technomed, Inc. · 510(k) 2025
- Exablate Model 2100V1Insightec, Ltd. · 510(k) 2023
- Tulsa Pro System (Pad-105)Profound Medical, Inc. · 510(k) 2024
- Ablatherm FusionEdap Technomed, Inc. · 510(k) 2017
- SonablateSonacare Medical, LLC · 510(k) 2016
- Ablatherm Integrated ImagingEdap Technomed, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.